MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MP-24-0012542
Bionovics Pharmaceuticals Private Limited
Bionovics Pharmaceuticals Private Limited - chemicals in Jabalpur, Madhya Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2025
₹3.66 Cr
▲ 26% YoY
Net profit · FY 2025
₹12.22 Lakh
Net margin 3.3%
EBITDA · FY 2025
₹17.74 Lakh
EBITDA margin 4.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Bionovics Pharmaceuticals Private Limited
Data last updated:
Bionovics Pharmaceuticals Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 21 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2021PTC058036.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ekta Guglianie and Rishi Talwar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Shop No – 5 Patel Market Link Road, Jabalpur, Madhya Pradesh, India – 482002.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.66 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹12.22 Lakh (net margin 3.3%) and EBITDA of ₹17.74 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years.
Bionovics Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-24-0012542).
Company details
CIN U24290MP2021PTC058036
Registration Number 058036
Incorporation Date 21 October 2021
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-24-0012542
Recognitions & Rankings of Bionovics Pharmaceuticals
Contact details
Bionovics Pharmaceuticals Private Limited's registered office is in Jabalpur, Madhya Pradesh.
- Registered AddressGround Shop No – 5 Patel Market Link Road, Jabalpur, Madhya Pradesh, India – 482002
- IndustryChemicals, Other Chemical Product, Manufacturing
Comprehensive company report
Bionovics Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bionovics Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bionovics Pharmaceuticals Private Limited, buy the company report.
Financials of Bionovics Pharmaceuticals Private Limited
FY 2025 filings availableBionovics Pharmaceuticals Private Limited reported revenue of ₹3.66 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹3.66 Cr ▲ 26%
Net profit · FY 2025
₹12.22 Lakh margin 3.3%
EBITDA · FY 2025
₹17.74 Lakh margin 4.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 64%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 205%
Revenue has grown at a compounded annual rate (CAGR) of 64% over three years, including 26% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹17.74 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹12.22 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.9% | |||
| Net Profit Margin | 3.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Bionovics Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bionovics Pharmaceuticals Private Limited
Bionovics Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ekta Guglianie | Director | 21 Oct 2021 | 5 Years 0 Months | Current |
| Rishi Talwar Also directs: Livelife Meditech and Pharma Private Limited | Additional Director | 01 Sep 2022 | 4 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Bionovics Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bionovics Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bionovics Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bionovics Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Rishi Talwar was appointed as Additional Director on 01 Sep 2022.
AGM
Bionovics Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bionovics Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Rishi Talwar was appointed as Additional Director.
Ceased
Vivek Guglianie ceased to be Director.
Appointed
Ekta Guglianie was appointed as Director.
Incorporation
21 Oct 2021
Bionovics Pharmaceuticals Private Limited was registered on 21 Oct 2021 with Roc Gwalior & aged 5 years 15 days as per MCA records.
Frequently asked questions
Bionovics Pharmaceuticals is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 21 October 2021 (5+ years old) and is registered under CIN U24290MP2021PTC058036.
Bionovics Pharmaceuticals has 2 current directors:
- Ekta Guglianie - Director
- Rishi Talwar - Additional Director
The latest financial statements of Bionovics Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Bionovics Pharmaceuticals is U24290MP2021PTC058036. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bionovics Pharmaceuticals was incorporated on 21 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
Rishi Talwar was appointed as Additional Director on 01 Sep 2022. Vivek Guglianie ceased to be Director on 31 Aug 2022. Ekta Guglianie was appointed as Director on 21 Oct 2021.
Yes, Bionovics Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-24-0012542).
The registered office of Bionovics Pharmaceuticals is at Ground Shop No – 5 Patel Market Link Road, Jabalpur, Madhya Pradesh, India – 482002.
Bionovics Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
Bionovics Pharmaceuticals can be reached at its registered office: Ground Shop No – 5 Patel Market Link Road, Jabalpur, Madhya Pradesh, India – 482002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages